Press release

Veeva Announces New Mobile and AI Innovations in Veeva CRM

Sponsored by Businesswire

2019 Veeva Commercial & Medical Summit — Veeva
(NYSE:VEEV) today announced two new innovations in Veeva
that continue to advance compliance and digital engagement in
the life sciences industry. Veeva CRM Approved Notes makes it easy for
field reps to capture free text notes in Veeva CRM and leverage the
power of artificial intelligence (AI) to save information without risk.
Veeva Approved Messaging will add support for messaging applications
such as WeChat and WhatsApp to open up new digital channels for
compliant engagement.

These latest innovations build upon Veeva’s continued investment in the
industry’s leading CRM platform, including Veeva CRM’s real-time
architecture to ensure field reps can access CRM details when and where
they need them from any device.

“We continue to deliver industry-first capabilities that help companies
provide the best customer experience with Veeva CRM,” said Arno Sosna,
general manager of Veeva CRM. “With rich note-taking in Veeva CRM
Approved Notes and the ability for reps to send personalized messages
with Veeva CRM Approved Messaging, organizations can build better
customer relationships and remain compliant with every interaction.”

Veeva is advancing the industry’s efficiency and effectiveness with the
following innovative capabilities in Veeva CRM:

  • Veeva CRM Approved Notes will be a new capability
    included in Veeva CRM that allows field reps to compliantly capture
    detailed notes of customer interactions. AI in Veeva CRM will help
    automatically detect potential compliance risks such as off-label
    messaging. With the freedom and flexibility to capture rich notes,
    reps can build stronger relationships and drive smarter, more informed
    customer interactions with lower risk. Veeva Approved Notes is planned
    for availability in 2020.
  • Veeva CRM Approved Messaging will open up new digital
    channels for reps to engage in relevant, timely interactions with
    healthcare professionals. Companies can use messaging applications,
    including WhatsApp and WeChat, to send compliant messages to customers
    through any mobile device. Messaging now gives reps another digital
    channel to reach and engage HCPs and drive a personalized customer
    experience. Veeva Approved Messaging is available today for WeChat.
    Availability for WhatsApp is planned for 2020.
  • Veeva CRM’s real-time architecture and Autosync
    capability will ensure all information is consistent across all
    devices. Activity, customer, and product data will automatically
    synchronize and always be available from any Apple and Windows phone,
    tablet, and laptop. With advanced mobile innovations in Veeva CRM,
    field teams can access the information they need for improved
    execution and productivity. Veeva CRM’s Autosync is planned for
    availability in August 2019. See our infographic
    to learn how Veeva CRM is enabling real-time reps to do more from any
    device, anywhere.

Veeva helps customers stay current with the most recent enhancements
from leading platform and operating system providers. Looking ahead,
Veeva CRM will leverage the latest innovations from Apple, Microsoft,
and Salesforce. Planned for availability in 2020, Veeva CRM will work
with Apple touch ID and face ID to make it fast and easy for field reps
to securely log in and open their CRM application. Veeva CRM’s Sunrise
user interface
is now available on Windows 10 devices to provide a
consistent and intuitive mobile experience for Windows users across all
devices. And Veeva CRM is expected to be Lightning ready by the end of
2019 so customers can leverage Salesforce’s new user interface for
online browsers.

In other news today, Veeva introduced Veeva
, a new AI application as part of the Veeva
CRM Suite
that embeds tailored insights and suggestions right in
Veeva CRM. Veeva also announced new capabilities in Veeva Commercial
Cloud, including Veeva Vault Auto Claims Linking in Veeva
Vault PromoMats
to help improve speed and compliance of content
development. Read today’s Veeva
Andi press release
and Veeva
Commercial Cloud press release
to learn more.

Additional Information

For more information on Veeva CRM, visit:

Connect with Veeva on LinkedIn:

Follow @veevasystems on Twitter:

Like Veeva on Facebook:

About Veeva Systems

Veeva Systems Inc. is the leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva serves more than 700 customers, ranging from the
world’s largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices throughout
North America, Europe, Asia, and Latin America. For more information,

Forward-looking Statements

This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-K for the period ended January 31, 2019. This is available on the
company’s website at under
the Investors section and on the SEC’s website at
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to